A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED 12-WEEK TRIAL OF EPLIVANSERIN IN INSOMNIAC PATIENTS WITH SLEEP MAINTENANCE DIFFICULTIES

被引：0
|
作者：
Erman, M. [1 ]
Kryger, M. [2 ]
Soubrane, C. [3 ]
Morin, C. [4 ]
Hajak, G. [5 ]
机构：
[1] Pacific Sleep Med Res, San Diego, CA USA
[2] Gaylord Hosp, Wallingford, CT USA
[3] Sanofi Aventis Rech & Dev, Chilly Mazarin, France
[4] Univ Laval, Ste Foy, PQ, Canada
[5] Klin & Poliklin Psychiat & Psychotherapie, Regensburg, Germany
来源：
SLEEP | 2009年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
121
引用
收藏
页码：A41 / A41
页数：1
相关论文
共 50 条
  • [1] A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED 12-WEEK TRIAL OF EPLIVANSERIN WITH LONG-TERM OPEN EXTENSION IN INSOMNIAC PATIENTS WITH SLEEP MAINTENANCE DIFFICULTIES: RESULTS FROM THE DOUBLE-BLIND TREATMENT PERIOD
    Estivill, E.
    Leger, D.
    Soubrane, C.
    SLEEP, 2009, 32 : A41 - A41
  • [2] Effects of Panax ginseng extract in patients with fibromyalgia: A 12-week, randomized, double-blind, placebo-controlled trial
    Braz, Alessandra S.
    Morais, Liana Clebia S.
    Paula, Ana Patrica
    Diniz, Margareth F. F. M.
    Almeida, Reinaldo N.
    REVISTA BRASILEIRA DE PSIQUIATRIA, 2013, 35 (01) : 21 - 28
  • [3] A randomized, double-blind, placebo-controlled 12-week trial of infliximab in patients with juvenile-onset spondyloarthritis
    Burgos-Vargas, Ruben
    Loyola-Sanchez, Adalberto
    Ramiro, Sofia
    Reding-Bernal, Arturo
    Alvarez-Hernandez, Everardo
    van der Heijde, Desiree
    Vazquez-Mellado, Janitzia
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [4] A randomized, double-blind, placebo-controlled 12-week trial of infliximab in patients with juvenile-onset spondyloarthritis
    Rubén Burgos-Vargas
    Adalberto Loyola-Sanchez
    Sofia Ramiro
    Arturo Reding-Bernal
    Everardo Alvarez-Hernandez
    Desirée van der Heijde
    Janitzia Vázquez-Mellado
    Arthritis Research & Therapy, 24
  • [5] Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: A 12-week, randomized, double-blind, placebo-controlled trial
    Malhotra, AK
    Keefe, R
    Meltzer, H
    Kane, J
    Murthy, A
    Sovel, M
    Xu, YK
    Gold, L
    Goldman, R
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S171 - S171
  • [6] Add-on Treatment of Quetiapine for Fibromyalgia A Pilot, Randomized, Double-Blind, Placebo-Controlled 12-Week Trial
    Potvin, Stephane
    Morin, Melanie
    Cloutier, Christian
    Gendron, Alain
    Bissonnette, Alain
    Marchand, Serge
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (05) : 684 - 687
  • [7] A 12-Week Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Topiramate for the Treatment of Compulsive Buying Disorder
    de Mattos, Cristiana
    Kim, Hyoun S.
    Marasaldi, Renata F.
    Requiao, Marinalva G.
    de Oliveira, Elen Cristina
    Filomensky, Tatiana
    Tavares, Hermano
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2020, 40 (02) : 186 - 190
  • [8] Icosabutate for the treatment of very high triglycerides: A placebo-controlled, randomized, double-blind, 12-week clinical trial
    Bays, Harold E.
    Hallen, Jonas
    Vige, Runar
    Fraser, David
    Zhou, Rong
    Hustvedt, Svein Olaf
    Orloff, David G.
    Kastelein, John J. P.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (01) : 181 - 191
  • [9] The effects of empagliflozin in patients with type 1 diabetes: Results of a 12-week, double-blind, randomized, placebo-controlled clinical trial
    Najafipour, Mostafa
    Najafipour, Farzad
    Ostadrahimi, Alireza
    Ghavami, Maryam
    Razaghi, Zohreh
    Tutunchi, Helda
    Alamdari, Naimeh Mesri
    HEALTH PROMOTION PERSPECTIVES, 2024, 14 (04): : 380 - 387
  • [10] Effects of Simvastatin on Plasma Amyloid-β Transport in Patients with Hyperlipidemia: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial
    Wei, Shan
    Dang, Liangjun
    Gao, Fan
    Wang, Jingyi
    Wang, Jin
    Qu, Qiumin
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 90 (01) : 349 - 362
12345